| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $643.3M | -17.4% | -3.0% |
| Cost of Revenue | $384.5M | -26.4% | -4.8% |
| Gross Profit | $258.8M | +0.9% | -0.1% |
| R&D Expense | $7.6M | -2.6% | -6.2% |
| SG&A Expense | $133.1M | -10.9% | -2.1% |
| Interest Expense | $39.3M | +0.5% | +3.4% |
| Pre-tax Income | $21.7M | +552.1% | -40.4% |
| Income Tax | $11.6M | +928.6% | +43.2% |
| Net Income | $10.1M | +397.1% | -64.3% |
| EPS (Basic) | $0.15 | +400.0% | -61.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $172.5M | -19.7% | +23.8% |
| Accounts Receivable | $309.6M | -17.0% | +1.5% |
| Inventory | $743.6M | +3.2% | -0.7% |
| Current Assets | $1.50B | -4.0% | +7.5% |
| Total Assets | $4.40B | -1.0% | +4.4% |
| Current Liabilities | $732.0M | -6.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $147.8M | -1.1% | — |
| Capital Expenditures | $43.0M | +70.0% | — |
| Investing Cash Flow | -$41.9M | -65.6% | — |
| Financing Cash Flow | -$169.0M | -15.9% | — |
| Free Cash Flow | $104.8M | -15.6% | — |
| -2.3% |
| Long-term Debt | $3.30B | -0.4% | +4.7% |
| Total Liabilities | $4.23B | -1.8% | +3.6% |
| Stockholders' Equity | $173.2M | +22.6% | +29.4% |